Quick Takeaways
- FMR LLC filed SCHEDULE 13G for AMYLYX PHARMACEUTICALS INC COMMON STOCK (AMLX).
- Disclosed ownership: 11%.
- Date of event: 30 Sep 2025.
FMR LLC - 30 Sep 2025 SCHEDULE 13G Report for AMYLYX PHARMACEUTICALS INC COMMON STOCK (AMLX)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- AMLX
- Shares outstanding
- 106,347,729 shares
- Disclosed Ownership
- 11,379,207 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Oct 2025, 15:49:26 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 05 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 11% ownership in AMYLYX PHARMACEUTICALS INC COMMON STOCK (AMLX) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Oct 2025, 15:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 11% | 11,379,207 | 11,361,910 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 11% | 11,379,207 | 0 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** |